Hengrui Medicine (01276.HK) spent 89.9356 million yuan on September 23 to repurchase 1.298 million A shares.

The Citic Securities App reported that Hengrui Medicine (01276.HK) announced that on September 23, 2025, it spent 89.9356 million yuan to repurchase 1.298 million A shares.